All News

    Are We at Risk of Losing Our Breast Cancer Community?

    February 14th 2025, 6:00pm

    Article

    I found community after my metastatic breast cancer diagnosis, but recent discord in cancer support groups makes me fear we're losing these vital connections.

    Estrogen Patches with ARPIs Found to Be Safe, Effective in Prostate Cancer

    February 14th 2025, 5:15pm

    Article

    Responses were similar among patients with estrogen patches and ARPIs compared to luteinizing hormone releasing hormone analogues and ARPIs among patients with metastatic prostate cancer.

    Linvoseltamab BLA Resubmission Accepted by FDA for Review

    February 14th 2025, 2:00pm

    Article

    The FDA accepted Regeneron’s BLA resubmission for linvoseltamab in relapsed or refractory multiple myeloma, with a decision expected by July 10, 2025.

    Nubeqa Plus ADT Effective in mHSPC Regardless of Disease Volume

    February 13th 2025, 11:49pm

    Article

    Nubeqa plus ADT improved rPFS in mHSPC regardless of disease volume, reducing the risk of radiological progression or death by 46%, per ARANOTE data.

    Patients With Prostate Cancer Experience Temporary Urinary Function Decline After CIRT

    February 13th 2025, 10:00pm

    Article

    Although carbon ion radiation led to a decline in urinary function among patients with prostate cancer, function returned to normal after three months.

    An Expert Explains Updated Data For Patients With GU Cancers

    February 13th 2025, 9:35pm

    Video

    Dr. Guru P Sonpavde discusses updated data from studies like EV-302 and CheckMate 274 for patients with urothelial cancer at the 2025 ASCO GU meeting.

    Elevated PSA Link to Higher Recurrence Risk in Intermediate-Risk Prostate Cancer

    February 13th 2025, 8:45pm

    Article

    Among those with intermediate-risk prostate cancer, high PSA levels prior to HIFU led to an increased risk of overall recurrence and treatment failure.

    Facing Cancer Together: Jim and Melanie’s Patient-Caregiver Story

    February 13th 2025, 6:00pm

    Article

    Diagnosed with stage 3B lung cancer in 2018, I joined a support group where I met Jim and Melanie, and learned about Jim's sarcoma diagnosis.

    Breyanzi Improves Responses in R/R Indolent B-Cell Non-Hodgkin Lymphoma

    February 13th 2025, 4:00pm

    Article

    Breyanzi has shown significant efficacy and durable responses in patients with marginal zone lymphoma.

    Talzenna Plus Xtandi May Improve Survival in mCRPC

    February 13th 2025, 3:10pm

    Article

    Patients with HRR-deficient metastatic castration-resistant prostate cancer experienced a 14-month gain in OS and a 38% lower death risk with Talzenna plus Xtandi.